REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,422,402 | -52.4% | 1,780,277 | +5.0% | 0.00% | -60.0% |
| Q2 2023 | $42,913,374 | -16.5% | 1,695,510 | +6.2% | 0.01% | -28.6% |
| Q1 2023 | $51,423,738 | +181448.9% | 1,596,514 | +4.0% | 0.01% | +75.0% |
| Q4 2022 | $28,325 | -99.9% | 1,534,445 | +10.9% | 0.00% | -33.3% |
| Q3 2022 | $37,347,000 | +118.5% | 1,383,241 | +11.8% | 0.01% | +100.0% |
| Q2 2022 | $17,094,000 | -34.4% | 1,236,952 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $26,055,000 | +21.7% | 1,336,191 | +1.8% | 0.00% | 0.0% |
| Q4 2021 | $21,413,000 | -36.2% | 1,312,080 | +8.9% | 0.00% | -40.0% |
| Q3 2021 | $33,554,000 | -6.0% | 1,204,388 | +0.0% | 0.01% | 0.0% |
| Q2 2021 | $35,680,000 | +13.9% | 1,203,811 | +7.4% | 0.01% | 0.0% |
| Q1 2021 | $31,318,000 | +11.4% | 1,120,508 | +12.9% | 0.01% | 0.0% |
| Q4 2020 | $28,115,000 | +18.9% | 992,094 | +5.5% | 0.01% | 0.0% |
| Q3 2020 | $23,648,000 | +21.4% | 940,676 | +18.0% | 0.01% | +25.0% |
| Q2 2020 | $19,473,000 | +81.8% | 797,452 | +10.2% | 0.00% | +33.3% |
| Q1 2020 | $10,713,000 | -43.8% | 723,870 | -38.4% | 0.00% | +50.0% |
| Q4 2019 | $19,058,000 | +154.0% | 1,174,304 | +103.4% | 0.00% | 0.0% |
| Q3 2019 | $7,504,000 | +3.1% | 577,256 | +2.9% | 0.00% | 0.0% |
| Q2 2019 | $7,277,000 | -5.4% | 561,114 | +14.9% | 0.00% | 0.0% |
| Q1 2019 | $7,696,000 | -50.5% | 488,347 | -36.7% | 0.00% | 0.0% |
| Q4 2018 | $15,532,000 | +85.2% | 771,636 | +128.6% | 0.00% | 0.0% |
| Q3 2018 | $8,386,000 | +0.5% | 337,493 | +11.0% | 0.00% | -33.3% |
| Q2 2018 | $8,347,000 | +3.3% | 304,089 | +15.9% | 0.00% | 0.0% |
| Q1 2018 | $8,081,000 | +3.0% | 262,392 | +19.5% | 0.00% | 0.0% |
| Q4 2017 | $7,849,000 | +40.3% | 219,561 | +8.1% | 0.00% | +50.0% |
| Q3 2017 | $5,593,000 | +10.4% | 203,020 | +5.8% | 0.00% | 0.0% |
| Q2 2017 | $5,065,000 | +36.5% | 191,891 | +7.5% | 0.00% | 0.0% |
| Q1 2017 | $3,711,000 | +16.9% | 178,435 | +16.4% | 0.00% | +100.0% |
| Q4 2016 | $3,174,000 | +32.2% | 153,360 | +3.5% | 0.00% | 0.0% |
| Q3 2016 | $2,400,000 | +23.0% | 148,113 | +3.2% | 0.00% | 0.0% |
| Q2 2016 | $1,951,000 | -20.2% | 143,457 | +2.4% | 0.00% | 0.0% |
| Q1 2016 | $2,445,000 | -44.4% | 140,040 | +8.8% | 0.00% | -66.7% |
| Q4 2015 | $4,397,000 | +52.5% | 128,718 | +32.8% | 0.00% | +50.0% |
| Q3 2015 | $2,883,000 | +16.8% | 96,903 | +25.5% | 0.00% | +100.0% |
| Q2 2015 | $2,469,000 | +68.3% | 77,223 | +9.1% | 0.00% | 0.0% |
| Q1 2015 | $1,467,000 | +33.5% | 70,772 | +9.0% | 0.00% | 0.0% |
| Q4 2014 | $1,099,000 | -9.9% | 64,904 | +2.8% | 0.00% | 0.0% |
| Q3 2014 | $1,220,000 | -12.4% | 63,131 | +54.2% | 0.00% | 0.0% |
| Q2 2014 | $1,392,000 | +25.9% | 40,949 | +16.5% | 0.00% | 0.0% |
| Q1 2014 | $1,106,000 | – | 35,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |